wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34541663-CFEA6E18-D806-4FA2-B474-8CE3871BE8FC
Q34541663-CFEA6E18-D806-4FA2-B474-8CE3871BE8FC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34541663-CFEA6E18-D806-4FA2-B474-8CE3871BE8FC
Enrichment of c-Met+ tumorigenic stromal cells of giant cell tumor of bone and targeting by cabozantinib
P2860
Q34541663-CFEA6E18-D806-4FA2-B474-8CE3871BE8FC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34541663-CFEA6E18-D806-4FA2-B474-8CE3871BE8FC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f63fb300bb6a31c8db684d7223107a75f551851d
P2860
Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial.